Literature DB >> 6280861

Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis.

L L Vindeløv, H H Hansen, A Gersel, F R Hirsch, N I Nissen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280861

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  Flow Cytometric Assay of c-erbB-2 Protein in Fine Needle Aspirates of Fresh and Frozen Human Breast Cancer Tissues.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

Review 2.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

Review 3.  Predictive testing in cancer chemotherapy. I. In vivo.

Authors:  P H Slee; A T Van Oosterom; E A De Bruijn
Journal:  Pharm Weekbl Sci       Date:  1985-06-21

4.  DNA flow cytometry of breast cancer fine needle aspirates.

Authors:  Y Remvikos
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

5.  Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.

Authors:  R Berman; B Gusterson; G G Steel
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

6.  DNA flow cytometric study of 5-fluorouracil used to treat end stage non-Hodgkin's lymphoma.

Authors:  D W Hedley
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

7.  Disaggregation of human solid tumours by combined mechanical and enzymatic methods.

Authors:  S A Engelholm; M Spang-Thomsen; N Brünner; I Nøhr; L L Vindeløv
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

8.  Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice.

Authors:  N Brünner; M Spang-Thomsen; L Vindeløv; A Nielsen
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

9.  A short-term in vitro test for tumour sensitivity to adriamycin based on flow cytometric DNA analysis.

Authors:  S A Engelholm; M Spang-Thomsen; L L Vindeløv
Journal:  Br J Cancer       Date:  1983-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.